Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cara Therapeutics

5.32
0.0000
Volume:- -
Turnover:- -
Market Cap:16.59M
PE:- -
High:5.32
Open:5.32
Low:5.32
Close:5.32
Loading ...
OverviewCompanyNewsFilings

Cara Therapeutics Merges with Tvardi Therapeutics for STAT3 Focus

TIPRANKS
·
18 Dec 2024

Cara Therapeutics Agrees to Merge With Tvardi Therapeutics

MT Newswires Live
·
18 Dec 2024

Cara Therapeutics Inc - Dan Conn to Serve as CFO of Combined Company

THOMSON REUTERS
·
18 Dec 2024

Cara Therapeutics Subsidiary to Merge with Tvardi Therapeutics in All-Stock Deal

Dow Jones
·
18 Dec 2024

Cara Therapeutics Inc - to Sell Korsuva/Kapruvia Assets to CSL Vifor

THOMSON REUTERS
·
18 Dec 2024

Cara Therapeutics Inc - Stockholders to Own 17% of Combined Company, Tvardi Investors 83%

THOMSON REUTERS
·
18 Dec 2024

Cara Therapeutics and Tvardi Therapeutics Announce Entry Into Merger Agreement

THOMSON REUTERS
·
18 Dec 2024

BRIEF-Cara Therapeutics Inc - Receives Non-Compliance Notice From Nasdaq On Minimum Stockholders’ Equity Requirement

Reuters
·
23 Nov 2024

Cara Therapeutics Inc - Receives Non-Compliance Notice From Nasdaq on Minimum Stockholders’ Equity Requirement

THOMSON REUTERS
·
23 Nov 2024

Cara Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
17 Nov 2024

Analyst Rate

 
 
 
 

Corporate Actions

Split&Reverse Split
Apr 16, 2025 3 for 1
Symbol Change
Apr 16, 2025 TVRD
Financial Report Announcement
Mar 11, 2025 Post Market
Split&Reverse Split
Dec 31, 2024 12 for 1
Financial Report Announcement
Nov 14, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.36
Current
10.97
Sector Average
57.40%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.36
Maximum
173.12
+1 STD
45.15
Minimum
-10.07
-1 STD
-23.20
Average
10.97

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.